Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Daniel Willis

Set Alert for Articles By Daniel Willis

Latest From Daniel Willis

GALVmed receives funding approval for Tryps Phase 3 program

GALVmed has received funding totaling $19 million for its Improved Tools for the Control of Animal African Trypanosomosis, Phase 3 (Tryps 3) program.

Pharmaceuticals R&D

Ouro Fino records highest stock valuation since March

Ouro Fino Saúde Animal has recorded its highest share price since March earlier this year, following third-quarter double-digit growth.

Ouro Fino Saude Animale

MSD expands Paracox vaccine supply with new manufacturing facility

MSD Animal Health has strengthened its UK market by opening a new manufacturing, packaging and warehousing facility in Milton Keynes.

Merck MSD Animal Health Vaccines

Delacon launches feed additive to address post-weaning challenges

Delacon has launched Fresta Protect, which is a phytogenic feed additive to address post-weaning challenges for piglets.

Feed & Additives Porcine

Ghanaian animal health start-up receives $300,000 funding

Ghanaian animal health start-up Cowtribe has received $300,000 funding from Draper Richards Kaplan – an American foundation that funds early-stage companies in Africa.

Investments Bovine

Virbac shares highest for over a year

Virbac has recorded its highest stock valuation in over a year – trading at a price of 147.40 ($166.38) per share on November 9, 2018.

See All